DIANA MOORE: Open Payments
NPI 1396342218 · CLEBURNE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$416 in 19 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $387 · 2025 $416
Food & beverage: $416
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $186 |
| Amgen Inc. | 7 | $116 |
| PFIZER INC. | 3 | $55 |
| ABIOMED | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $18 |
Products named: JARDIANCE, Repatha, ELIQUIS, VYNDAQEL, NEXLETOL.
Industry payments across TX — which companies pay providers there.
